K784-2633 Screening compound: N1-[(4-methoxyphenyl)methyl]-N2-(1-{[(4-methoxyphenyl)methyl]carbamoyl}-2-methylbutyl)benzene-1,2-dicarboxamide

K784-2633 Screening compound: N1-[(4-methoxyphenyl)methyl]-N2-(1-{[(4-methoxyphenyl)methyl]carbamoyl}-2-methylbutyl)benzene-1,2-dicarboxamide
K784-2633 Screening compound: N1-[(4-methoxyphenyl)methyl]-N2-(1-{[(4-methoxyphenyl)methyl]carbamoyl}-2-methylbutyl)benzene-1,2-dicarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K784-2633
N1-[(4-methoxyphenyl)methyl]-N2-(1-{[(4-methoxyphenyl)methyl]carbamoyl}-2-methylbutyl)benzene-1,2-dicarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K784-2633

Molecular Formula

C30H35N3O5 (C30 H35 N3 O5)

Compound Name

N1-[(4-methoxyphenyl)methyl]-N2-(1-{[(4-methoxyphenyl)methyl]carbamoyl}-2-methylbutyl)benzene-1,2-dicarboxamide

IUPAC name

N1-[(4-methoxyphenyl)methyl]-N2-(1-{[(4-methoxyphenyl)methyl]carbamoyl}-2-methylbutyl)benzene-12-dicarboxamide

SMILES

CCC(C)C(C(NCc(cc1)ccc1OC)=O)NC(c(cccc1)c1C(NCc(cc1)ccc1OC)=O)=O

InChI

InChI=1S/C30H35N3O5/c1-5-20(2)27(30(36)32-19-22-12-16-24(38-4)17-13-22)33-29(35)26-9-7-6-8-25(26)28(34)31-18-21-10-14-23(37-3)15-11-21/h6-17,20,27H,5,18-19H2,1-4H3,(H,31,34)(H,32,36)(H,33,35)

InChI Key

OESWJBPBZZLFDU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03450733

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

517.63

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

15.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.388

Distribution Coefficient, logD

4.388

Water Solubility, LogSw

-4.36

Polar Surface Area

88.190

Acid Dissociation Constant (pKa)

12.36

Base Dissociation Constant (pKb)

-1.91

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

30.00

K784-2633 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SH2 Library (10483 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with K784-2633 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K784-2633?
Check Price and Availability of K784-2633, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K784-2633 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K784-2633
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K784-2633
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K784-2633 available by request